Skip to main content

Soleus Capital Management, L.P.

Source: SEC Form 13F · as of Mar 2026

Soleus Capital Management, L.P. holds 41 biotech & pharma companies tracked by BioSniper, totaling $691.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

41

Total value held

$691.1M

BioSniper AIPage evidence connected

Prepared research question

What matters most for TG THERAPEUTICS, INC. (TGTX)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
TGTXTG THERAPEUTICS, INC.4,029,319$133.9M
VCELVericel Corp2,549,079$82.0M
ANIPANI PHARMACEUTICALS INC820,243$63.1M
GERNGERON CORP41,508,659$61.8M
ALNYALNYLAM PHARMACEUTICALS, INC.131,650$43.6M
BMRNBIOMARIN PHARMACEUTICAL INC650,572$36.8M
KNSAKiniksa Pharmaceuticals International, plc521,353$25.1M
ORGOOrganogenesis Holdings Inc.10,085,951$23.9M
PCVXVaxcyte, Inc.385,472$22.4M
PHVSPharvaris N.V.702,052$19.8M
CNTXContext Therapeutics Inc.6,963,141$18.2M
TVTXTravere Therapeutics, Inc.546,000$16.2M
NRIXNurix Therapeutics, Inc.938,163$14.5M
SIONSionna Therapeutics, Inc.293,500$11.8M
JBIOJade Biosciences, Inc.796,744$11.2M
IVVDInvivyd, Inc.7,708,727$10.0M
CCCCC4 Therapeutics, Inc.3,803,942$10.0M
RCUSArcus Biosciences, Inc.451,983$9.8M
TNGXTango Therapeutics, Inc.450,000$9.4M
ELVNEnliven Therapeutics, Inc.230,869$9.1M
AVTXAvalo Therapeutics, Inc.441,978$6.6M
RLMDRELMADA THERAPEUTICS, INC.842,106$5.9M
CGEMCullinan Therapeutics, Inc.410,200$5.8M
IMVTImmunovant, Inc.230,000$5.7M
IMUXIMMUNIC, INC.4,500,000$5.0M
LRMRLarimar Therapeutics, Inc.1,066,960$4.8M
SABSSAB BIOTHERAPEUTICS, INC.1,050,000$4.0M
GPCRStructure Therapeutics Inc.80,000$3.9M
TECXTectonic Therapeutic, Inc.121,684$3.8M
IOVAIOVANCE BIOTHERAPEUTICS, INC.1,000,000$3.5M
ARGXARGENX SE3,500$2.6M
ARWRARROWHEAD PHARMACEUTICALS, INC.28,479$1.8M
INSMINSMED Inc10,250$1.7M
CTMXCytomX Therapeutics, Inc.300,000$1.4M
QNRXQuoin Pharmaceuticals, Ltd.72,730$480K
COGTCogent Biosciences, Inc.10,000$385K
ANABANAPTYSBIO, INC6,000$333K
ZYMEZymeworks Inc.10,000$250K
LBRXLB PHARMACEUTICALS INC10,000$247K
ORKAOruka Therapeutics, Inc.5,000$245K
JSPRJasper Therapeutics Inc.276,312$242K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.